These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
112 related items for PubMed ID: 3681663
41. Rescue from hypervitaminosis A or potentiation of retinoid toxicity by different modes of cyclodextrin administration. Pitha J, Szente L. Life Sci; 1983 Feb 14; 32(7):719-23. PubMed ID: 6827906 [No Abstract] [Full Text] [Related]
42. [Pharmacological studies on the clathrate compound of mobenzoxamine with beta-cyclodextrin. (I). Effects on the digestive system]. Yokochi E, Kohno S, Ohata K. Nihon Yakurigaku Zasshi; 1988 Nov 14; 92(5):297-310. PubMed ID: 3243512 [Abstract] [Full Text] [Related]
47. Inhibition of calcium transport in sarcoplasmic reticulum after modification of highly reactive amino groups. Hidalgo C. Biochem Biophys Res Commun; 1980 Feb 12; 92(3):757-65. PubMed ID: 6444814 [No Abstract] [Full Text] [Related]
48. The vasoinhibitory action of FR 46171, a new pyridine alcohol antianginal agent, on isolated rabbit vascular smooth muscles. Shibata S, Satake N, Kurahashi K, Ohtsuka M. J Cardiovasc Pharmacol; 1988 May 12; 11(5):601-7. PubMed ID: 2455847 [Abstract] [Full Text] [Related]
49. Cyclodextrin-induced hemolysis and shape changes of human erythrocytes in vitro. Irie T, Otagiri M, Sunada M, Uekama K, Ohtani Y, Yamada Y, Sugiyama Y. J Pharmacobiodyn; 1982 Sep 12; 5(9):741-4. PubMed ID: 7153847 [Abstract] [Full Text] [Related]
51. Effects of cyclodextrins on chlorpromazine-induced haemolysis and central nervous system responses. Uekama K, Irie T, Sunada M, Otagiri M, Iwasaki K, Okano Y, Miyata T, Kasé Y. J Pharm Pharmacol; 1981 Nov 12; 33(11):707-10. PubMed ID: 6118408 [Abstract] [Full Text] [Related]
53. Transdermal permeation modulation by cyclodextrins: a mechanistic study. Williams AC, Shatri SR, Barry BW. Pharm Dev Technol; 1998 Aug 12; 3(3):283-96. PubMed ID: 9742549 [Abstract] [Full Text] [Related]
54. Cyclodextrins as co-enhancers in dermal and transdermal drug delivery. Loftsson T, Másson M, Sigurdsson HH, Magnússon P, Le Goffic F. Pharmazie; 1998 Feb 12; 53(2):137-9. PubMed ID: 9540112 [No Abstract] [Full Text] [Related]
55. [Inhibition of pulmonary metastases in mice by beta-cyclodextrin-benzaldehyde]. Masuyama K, Ochiai H, Ishizawa S, Yamashita I, Matsui H, Tazawa K, Niwayama S, Fujimaki M. Gan To Kagaku Ryoho; 1988 Mar 12; 15(3):443-7. PubMed ID: 3348630 [Abstract] [Full Text] [Related]
56. Effect of 2-hydroxypropyl-beta-cyclodextrin on percutaneous absorption of methyl paraben. Tanaka M, Iwata Y, Kouzuki Y, Taniguchi K, Matsuda H, Arima H, Tsuchiya S. J Pharm Pharmacol; 1995 Nov 12; 47(11):897-900. PubMed ID: 8708982 [Abstract] [Full Text] [Related]
57. A study of the percutaneous absorption-enhancing effects of cyclodextrin derivatives in rats. Vollmer U, Müller BW, Peeters J, Mesens J, Wilffert B, Peters T. J Pharm Pharmacol; 1994 Jan 12; 46(1):19-22. PubMed ID: 8201522 [Abstract] [Full Text] [Related]
58. Effect of diethyl-beta-cyclodextrin on the release of nitroglycerin from formulations. Umemura M, Ueda H, Tomono K, Nagai T. Drug Des Deliv; 1990 Oct 12; 6(4):297-310. PubMed ID: 2128021 [Abstract] [Full Text] [Related]
59. Penetration of hydrocortisone into excised human skin under the influence of cyclodextrins. Preiss A, Mehnert W, Frömming KH. Pharmazie; 1995 Feb 12; 50(2):121-6. PubMed ID: 7700965 [Abstract] [Full Text] [Related]
60. Enhanced absorption of phenobarbital from suppositories containing phenobarbital-beta-cyclodextrin inclusion complex. Iwaoku R, Arimori K, Nakano M, Uekama K. Chem Pharm Bull (Tokyo); 1982 Apr 12; 30(4):1416-21. PubMed ID: 7105261 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]